Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.310
-0.070 (-2.07%)
Nov 18, 2026, 10:30 AM EST - Market open
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $525.01 million as of November 18, 2026. It is the 13,604th most valuable company in the world and the 2,622nd biggest in the United States. Its market cap has increased by 92.31% in one year.
Market Cap
525.01M
Enterprise Value
322.11M
1-Year Change
92.31%
Global Rank
Country Rank
#2,622 United States
Category
ChartMarket Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.50M to $525.01M, an increase of 144.76%. That is a compound annual growth rate of 8.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 571.80M | 75.34% |
| Dec 31, 2025 | 326.10M | 84.13% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
| Oct 7, 2015 | 214.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 597.92M |
| Climb Bio | 583.86M |
| Crescent Biopharma | 577.81M |
| Wave Life Sciences | 566.05M |
| Sana Biotechnology | 563.31M |
| Iambic Therapeutics | 561.70M |
| Orchestra BioMed Holdings | 560.38M |
| Helus Pharma | 560.37M |